Published October 1989
| Version v1
Journal article
The clinical advantages of I-125 seeds as a substitute for Ir-192 seeds in temporary plastic tube implants
- 1. William Beaumont Hospital, Royal Oak, MI (USA)
Description
In August of 1986 at William Beaumont Hospital, Iodine-125 (I-125) seeds were introduced in the clinical practice as a substitute for Iridium-192 (Ir-192) seeds in patients undergoing temporary plastic tube interstitial implants. Through February 1988, 108 I-125 implants were performed in 105 patients. Acute and chronic toxicity was indistinguishable from Ir-192. However, improved radiation safety and a dynamic dosimetric program have resulted from this endeavor. Because of the multiple clinical advantages of I-125, we feel that this should be considered the isotope of choice in temporary interstitial plastic tube implants
Additional details
Publishing Information
- Journal Title
- International Journal of Radiation Oncology, Biology and Physics
- Journal Volume
- 17
- Journal Issue
- 4
- Series
- Int. J. Radiat. Oncol., Biol. Phys.
- Journal Page Range
- 859-863
- ISSN
- 0360-3016
- CODEN
- IOBPD
INIS
- Country of Publication
- United States
- Country of Input or Organization
- United States
- INIS RN
- 21019886
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- COMPARATIVE EVALUATIONS; IODINE 125; IRIDIUM 192; NEOPLASMS; PATIENTS; RADIATION DOSES; RADIATION SOURCE IMPLANTS; RADIOTHERAPY
- Descriptors DEC
- BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; DAYS LIVING RADIOISOTOPES; DISEASES; ELECTRON CAPTURE RADIOISOTOPES; EVALUATION; HEAVY NUCLEI; IMPLANTS; INTERMEDIATE MASS NUCLEI; INTERNAL CONVERSION RADIOISOTO; IODINE ISOTOPES; IRIDIUM ISOTOPES; ISOMERIC TRANSITION ISOTOPES; ISOTOPES; MEDICINE; MINUTES LIVING RADIOISOTOPES; NUCLEI; ODD-EVEN NUCLEI; ODD-ODD NUCLEI; RADIATION SOURCES; RADIOISOTOPES; THERAPY; YEARS LIVING RADIOISOTOPES